Search for: "Teva Pharmaceuticals" Results 1001 - 1020 of 1,430
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Dec 2018, 3:53 am by Edith Roberts
Teva Pharmaceuticals. [read post]
Last month, San Francisco reached a $58 million settlement with Teva Pharmaceutical Industries and Allergan for fueling the opioid epidemic in the city. [read post]
22 Oct 2020, 8:23 am by Léon Dijkman
It cites and follows two notable precedents in which similar conclusions were reached: a 2012 decision in proceedings between Boehringer Ingelheim and Teva [here] and a 2016 decision between Novartis and Teva [here]. [read post]
4 Feb 2020, 5:00 am by Jason Rantanen
Teva Pharmaceuticals USA, Inc., the Supreme Court, in its first case addressing the AIA’s § 102, rejected this argument. [read post]
21 Jul 2010, 1:05 am by Kelly
Lupin Pharmaceuticals, Inc (FDA Law Blog) Olux (Clobetasol) – Perrigo confirms patent challenge for Colobetasol propionate emulsion foam (GenericsWeb) Prandin (Repaglinide) – US: Actavis, Sandoz bring inequitable conduct counterclaims against Novo Nordisk in Prandin suit (Patent Docs) Protonix (Pantoprazole) – US: District Court New Jersey denies Teva’s motion to overturn jury verdict finding the patent in suit not invalid in Protonix litigation (SmartBrief)… [read post]
1 Nov 2011, 6:08 am by Darren Tobin
Birth-control pills containing drospirenone include Bayer’s Yaz, Yasmin, Beyaz, Safyral; Sandoz’s Syeda and Loryna; Barr Laboratories’ Ocella; Watson Pharmaceuticals’ Zarah; and Teva Pharmaceuticals' Loryna. [read post]
4 Nov 2011, 3:46 am
 The substance of the seminar was provided by Dr Galit Gonen (who heads up the European patent litigation team at Teva Pharmaceuticals), the presentation being based on her doctoral thesis. [read post]
5 Oct 2016, 6:59 pm by Rik Lambers
One concerns the MSD / Teva litigation over the use of ribavirin for the manufacture of a pharmaceutical composition for treating a specific sub-group of patients having chronic hepatitis suffering from HCV-infection. [read post]
15 Jan 2010, 10:39 am by Hopkins
The manufacturer of all these “animal drugs”, Teva Pharmaceutical, also manufactures many drugs for humans as well. [read post]
17 Aug 2010, 4:30 am by Laura Simons
Finally, as we previously reported here, Israel-based Teva Pharmaceutical Industries recently announced it would stop production of its widely used sedative propofol, after two headline-grabbing events issued blows to both its image and its financial well being. [read post]
19 Oct 2010, 10:42 pm by Marie Louise
  General WTO paragraph 6 meeting aims at improved use of health waiver (IP Watch) The absence of investment in new antibiotics (IPBiz) Integration of intellectual property and regulatory exclusivity strategies for life science companies (IP Spotlight) Pharmaceutical companies can innovate if they want to (profitability through simplicity) Medicines Patent Pool seeks business director (IP Watch) WHO moves IP, innovation out of Director General’s office (IP Watch) A rights-poor… [read post]
9 Dec 2011, 2:30 pm by Jonathan H. Adler
Earlier this week, in response to a petition from Teva Pharmaceuticals, the manufacturer of Plan-B One Step, the Food and Drug Administration decided that the age limitations should be lifted. [read post]
1 Apr 2008, 2:16 am
Teva Pharmaceuticals USA, Inc. [read post]
30 Dec 2021, 2:20 am by HR Daily Advisor Staff
Our team at HR Daily Advisor has gone back through the archives and selected some of our favorite Faces of HR profiles from 2021: Don’t Be Afraid to be Uncomfortable (Janine Ting Jansen, Senior Director of Diversity & Inclusion at Teva Pharmaceuticals) For more than a decade, Janine Ting Jansen, Senior Director of Diversity & Inclusion at Teva Pharmaceuticals, has embraced the spirit of inclusiveness and called upon others she has not only… [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment calculation in respect… [read post]